Literature DB >> 34529467

Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.

Edoardo Del Poggetto1, I-Lin Ho1,2, Chiara Balestrieri3,4, Er-Yen Yen1,2, Shaojun Zhang1, Francesca Citron1, Rutvi Shah1,2, Denise Corti1, Giuseppe R Diaferia5, Chieh-Yuan Li1,2, Sara Loponte1, Federica Carbone1, Yoku Hayakawa6, Giovanni Valenti6, Shan Jiang1, Luigi Sapio1, Hong Jiang1, Prasenjit Dey7, Sisi Gao1, Angela K Deem1, Stefan Rose-John8, Wantong Yao9, Haoqiang Ying10, Andrew D Rhim11, Giannicola Genovese12, Timothy P Heffernan13, Anirban Maitra14, Timothy C Wang6, Linghua Wang1, Giulio F Draetta1, Alessandro Carugo13, Gioacchino Natoli5,15, Andrea Viale1.   

Abstract

Inflammation is a major risk factor for pancreatic ductal adenocarcinoma (PDAC). When occurring in the context of pancreatitis, KRAS mutations accelerate tumor development in mouse models. We report that long after its complete resolution, a transient inflammatory event primes pancreatic epithelial cells to subsequent transformation by oncogenic KRAS. Upon recovery from acute inflammation, pancreatic epithelial cells display an enduring adaptive response associated with sustained transcriptional and epigenetic reprogramming. Such adaptation enables the reactivation of acinar-to-ductal metaplasia (ADM) upon subsequent inflammatory events, thereby limiting tissue damage through a rapid decrease of zymogen production. We propose that because activating mutations of KRAS maintain an irreversible ADM, they may be beneficial and under strong positive selection in the context of recurrent pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34529467     DOI: 10.1126/science.abj0486

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  15 in total

Review 1.  Inflammatory memory and tissue adaptation in sickness and in health.

Authors:  Shruti Naik; Elaine Fuchs
Journal:  Nature       Date:  2022-07-13       Impact factor: 69.504

Review 2.  Cellular and molecular mechanisms of plasticity in cancer.

Authors:  Stefan R Torborg; Zhuxuan Li; Jason E Chan; Tuomas Tammela
Journal:  Trends Cancer       Date:  2022-05-23

3.  SIGIRR Downregulation and Interleukin-1 Signaling Intrinsic to Renal Cell Carcinoma.

Authors:  Maria Elena Mantione; Ilenia Sana; Maria Giovanna Vilia; Michela Riba; Claudio Doglioni; Alessandro Larcher; Umberto Capitanio; Marta Muzio
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

Review 4.  The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer.

Authors:  Yuuki Ohara; Paloma Valenzuela; S Perwez Hussain
Journal:  Trends Cancer       Date:  2022-05-05

Review 5.  Epithelial-immune crosstalk in health and disease.

Authors:  Daniel Rosenblum; Shruti Naik
Journal:  Curr Opin Genet Dev       Date:  2022-04-20       Impact factor: 4.665

6.  Accelerated Generation of Extra-Islet Insulin-Producing Cells in Diabetic Rats, Treated with Sodium Phthalhydrazide.

Authors:  Musa T Abidov; Ksenia V Sokolova; Irina F Gette; Irina G Danilova
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

Review 7.  Keep a Little Fire Burning-The Delicate Balance of Targeting Sphingosine-1-Phosphate in Cancer Immunity.

Authors:  Catherine Olesch; Bernhard Brüne; Andreas Weigert
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

Review 8.  Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma.

Authors:  Marcus T T Roalsø; Øyvind H Hald; Marina Alexeeva; Kjetil Søreide
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

Review 9.  Nonresolving inflammation redux.

Authors:  Carl Nathan
Journal:  Immunity       Date:  2022-04-12       Impact factor: 43.474

10.  Finding Method in the Madness of Pancreatic Carcinogenesis.

Authors:  Mara H Sherman
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.